SS-31 (Elamipretide)

2S10

Mitochondria-targeted tetrapeptide (Forzinity). FDA-approved September 2025 for Barth syndrome—first FDA-approved mitochondria-targeted therapeutic.

>99%

Purity (HPLC)

Vials per Set

Dose Options

Select Your Dose

Each order includes 10 vials

SS-31 (Elamipretide) 10mg × 10 vials

Code: 2S10

Full Research Profile

Protocols, clinical evidence, interactions & more on Pep-Pedia